Idiopathic myelofibrosis: a retrospective study of 103 patients
- PMID: 2227619
Idiopathic myelofibrosis: a retrospective study of 103 patients
Abstract
The clinical course of 103 patients (50 males, 53 females; median age 59 years) with idiopathic myelofibrosis (IMF) seen at our hospital between 1967 and 1986 was analyzed retrospectively. Common symptoms and signs at the time of diagnosis were: myelofibrosis (96%), splenomegaly (84%), anemia (81%), osteosclerosis (45%), malaise (41%) and leukocytosis (41%). It was possible to follow the majority of patients without treatment or with transfusion therapy only for prolonged periods of time. The use of cytostatic drugs and radiotherapy was restricted as much as possible. Probably due to this treatment strategy the incidence of acute leukemia was low (5%). Major thromboembolic complications were seen in 19% of the patients. Median survival of the patients was 4.3 years. The prognostic influence of several disease parameters determined at the time of diagnosis was tested: age, sex, leukocytes, platelets, hemoglobin, reticulocytes, LDH, ANP-score, spleen size and percentage of peripheral blood blasts + promyelocytes had no significant influence on the length of survival. Osteosclerosis, a presumed sign of advanced disease, was not correlated with survival either.
Similar articles
-
[Primary myelofibrosis: description of a series of 53 patients].Med Clin (Barc). 1989 Apr 15;92(14):521-5. Med Clin (Barc). 1989. PMID: 2666765 Review. Spanish.
-
The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.Medicine (Baltimore). 1983 Nov;62(6):353-71. Medicine (Baltimore). 1983. PMID: 6633248
-
Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.Ann Hematol. 2003 Oct;82(10):605-11. doi: 10.1007/s00277-003-0719-9. Epub 2003 Aug 28. Ann Hematol. 2003. PMID: 14564478
-
Prognostic parameters in myeloid metaplasia: agnogenic versus postpolycythemic.Isr J Med Sci. 1976 Jun;12(6):534-42. Isr J Med Sci. 1976. PMID: 955869
-
Idiopathic myelofibrosis.Semin Hematol. 2005 Oct;42(4):248-58. doi: 10.1053/j.seminhematol.2005.05.018. Semin Hematol. 2005. PMID: 16210038 Review.
Cited by
-
Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.Ann Hematol. 1994 Apr;68(4):205-12. doi: 10.1007/BF01834368. Ann Hematol. 1994. PMID: 8003563